Long-term depot-medroxyprogesterone acetate and bone mineral density

Contraception

Volumn 59, Issue 1, 1999, Pages 25-29

  Tang, O S ^a   Tang, G ^a   Yip, P ^b   Li, B ^b   Fan, S ^c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c Family Planning Association of Hong Kong   (Hong Kong)

Author keywords

Bone loss; Bone mineral density; Depot medroxyprogesterone acetate; Long term

Indexed keywords

MEDROXYPROGESTERONE ACETATE;

ADULT; ARTICLE; BIRTH CONTROL; BONE ATROPHY; BONE DENSITY; BONE MINERAL; BONE TURNOVER; CALCIUM INTAKE; CASE CONTROL STUDY; CONTRACEPTION; DRUG EFFECT; DRUG SAFETY; FEMALE; HORMONAL REGULATION; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; OSTEOPOROSIS;

ASIA; BIOLOGY; CHINA; COMPARATIVE STUDIES; CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE--PHARMACODYNAMICS; CONTRACEPTIVE AGENTS, PROGESTIN--PHARMACODYNAMICS; CONTRACEPTIVE AGENTS--PHARMACODYNAMICS; CONTRACEPTIVE METHODS--SIDE EFFECTS; DEMOGRAPHIC FACTORS; DEPO-PROVERA--PHARMACODYNAMICS; DEVELOPING COUNTRIES; EASTERN ASIA; FAMILY PLANNING; INJECTABLES--SIDE EFFECTS; LONGTERM EFFECTS--WOMEN; MEDROXYPROGESTERONE ACETATE--PHARMACODYNAMICS; PHYSIOLOGY; POPULATION; POPULATION DYNAMICS; RESEARCH METHODOLOGY; RESEARCH REPORT; SKELETAL EFFECTS--WOMEN; STUDIES; TIME FACTORS; WOMEN;

ADULT; AGE FACTORS; AMENORRHEA; BODY MASS INDEX; BONE DENSITY; BONE RESORPTION; CALCIUM; CASE-CONTROL STUDIES; CHINA; CONTRACEPTIVE AGENTS, FEMALE; DENSITOMETRY, X-RAY; FEMALE; FEMUR; HUMANS; LUMBAR VERTEBRAE; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; QUESTIONNAIRES; REGRESSION ANALYSIS;

EID: 0033009026     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(98)00144-9     Document Type: Article

References (19)

1. Kaunitz A.M., Rosenfield A. Injectable contraception with depot-medroxyprogesterone acetate. Drug. 45:1993;854-865.
2. Breast cancer. Lancet. 338:1991;833-838.
3. Endometrial cancer. Int J Cancer. 49:1991;186-190.
4. Epithelial ovarian cancer. Int J Cancer. 49:1991;191-195.
5. Cundy T., Evans M., Roberts H., et al. Bone density in women receiving depot medroxyprogesterone acetate for contraception. Br Med J. 303:1991;13-16.
6. Taneepanichskul S., Intaraprasert S., Theppisai U., Chaturachinda K. Bone mineral density in long-term depot-medroxyprogesterone acetate acceptors. Contraception. 56:1997;1-3.
7. Gbolade B., Ellis S., Murby B., et al. Bone density in the long-term users of depot-medroxyprogesterone acetate. Br J Obstet Gynecol. 105:1988;790-794.
8. Mandel F.P., Davidson B.J., Erlik Y., et al. Effect of progestins on bone metabolism in postmenopausal women. J Reprod Med. 27:1982;511-514.
9. Prior J.C. Progesterone as a bone-trophic hormone. Endocrin Rev. 1:1990;386-398.
10. Lobo R.A., McCormick W., Singer F., Roy S. Depot medroxyprogesterone acetate compared with conjugated estrogens for the treatment of postmenopausal women. Obstet Gynecol. 63:1984;1-5.
11. Duncan M.H. Osteoporosis fractures. Br Med J. 308:1994;274.
12. Breslow N.E., Day N.E. Statistical Methods in Cancer Research, Vol 1. The Analysis of Case-Control Studies. 1980;IARC Scientific Publications, Lyon, France.
13. Szarewaki A., Hollingworth B., Guillebaud. Depot medroxyprogesterone acetate and osteoporosis. (letter) Br Med J. 308:1994;717.
14. Mehta S. Bone loss, contraception and lactation. Acta Obstet Gynecol Scand. 72:1993;148-156.
15. Hosie C.J., Hart D.M., Smith D.A. Different effect of long-term estrogen therapy on tracebular and cortical bone. Maturitas. 11:1989;137-145.
16. Gallagher J.C., Kabel W.T., Goldgar D. Effect of progestin therapy on cortical and trabecular bone comparison with estrogen . Am J Med. 90:1991;171-178.
17. Cundy T., Farquhar C.M., Cornish J., Reid I.R. Short-term effects of high dose oral medroxyprogesterone acetate on bone density in premenopausal women. J Clin Endocrinol Metab. 81:1996;1014-1017.
18. Prior J.C., Vigna Y.M., Wark J.D., et al. Premenopausal ovariectomy-related bone loss a randomised, double-blind, one year trial of conjugated estrogen or medroxyprogesterone acetate . J Bone Min Res. 12:1997;1851-1863.
19. Cundy T., Cornish J., Evans M.C., et al. Recovery of bone density in women who stop using medroxyprogesterone acetate. Br Med J. 308:1994;247-248.